Standard BioTools
(NASDAQ) LAB
Standard BioTools Financials at a Glance
Market Cap
$288.91M
Revenue (TTM)
$86.26M
Net Income (TTM)
-$94.08M
EPS (TTM)
-$0.25
P/E Ratio
-3.02
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Price
$0.73
Volume
35,131,284.573
Open
$0.74
Price
$0.73
Volume
35,131,284.573
Open
$0.74
Previous Close
$0.73
Daily Range
$0.70 - $0.77
52-Week Range
$0.70 - $1.72
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Price
$0.73
Volume
35,131,284.573
Open
$0.74
Previous Close
$0.73
Daily Range
$0.70 - $0.77
52-Week Range
$0.70 - $1.72
Estimated Earnings Date
Aug 10, 2026
LAB News
Why Fluidigm Stock Plunged Today
Why Fluidigm Stock Surged Today
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Standard BioTools
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
389
CEO
Michael Egholm, PhD
Website
www.standardbio.comHeadquarters
Boston, MA 02109, US
LAB Financials
Key Financial Metrics (TTM)
Gross Margin
48.30%
Operating Margin
-91.02%
Net Income Margin
-109.08%
Return on Equity
-20.80%
Return on Capital
-20.50%
Return on Assets
-14.72%
Earnings Yield
-33.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$288.91M
Shares Outstanding
390.37M
Volume
35.13M
Avg. Volume
3.04M
Financials (TTM)
Gross Profit
$41.66M
Operating Income
-$78.51M
EBITDA
-$81.51M
Operating Cash Flow
-$90.66M
Capital Expenditure
-$3.82M
Free Cash Flow
-$94.48M
Cash & ST Invst.
$455.18M
Total Debt
$29.49M
Standard BioTools Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$21.15M
+4.6%
Gross Profit
$11.31M
+2.3%
Gross Margin
53.48%
N/A
Market Cap
$288.91M
N/A
Market Cap/Employee
$744.62K
N/A
Employees
388
N/A
Net Income
-$45.22M
-73.7%
EBITDA
-$13.21M
+31.6%
Quarterly Fundamentals
Total Cash
$455.18M
+76.4%
Total Debt
$29.49M
-6.5%
Accounts Receivable
$16.64M
-53.1%
Inventory
$18.59M
-55.9%
Long Term Debt
$23.95M
-4.9%
Short Term Debt
$5.54M
-12.5%
Return on Assets
-14.72%
N/A
Return on Invested Capital
-13.15%
N/A
Free Cash Flow
-$47.17M
-33.5%
Operating Cash Flow
-$46.60M
-53.9%